That doesn't mean they are not thinking about it. Various breakthrough therapy designations are already granted for psilocybin within the treatment of resistant depression—that may be, depression that does not reply to not less than two differing kinds of antidepressants—as well as a broader approval could be over the horizon. https://chancegiorw.iyublog.com/29282573/the-definitive-guide-to-can-copyright-drugs-treat-pain